-
Mashup Score: 4Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma - 9 month(s) ago
The prognosis for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is poor. Glofitamab is a bispecific antibody that recruits T cells to tumor cells.
Source: https://www.nejm.orgCategories: Expert Picks, Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 1Covid-19 Vaccine Resource Center - 3 year(s) ago
The Covid-19 vaccine resource center includes a collection of articles, FAQs, and related content to help educate and empower clinicians and their practice.
Source: https://www.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @jrgralow: Nice resource on COVID vaccines with @paulsaxmd @NEJM https://t.co/KyJ8NX3CGk
-
-
Mashup Score: 2Covid-19 Vaccine Resource Center - 3 year(s) ago
The Covid-19 vaccine resource center includes a collection of articles, FAQs, and related content to help educate and empower clinicians and their practice.
Source: https://www.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Nice resource on COVID vaccines with @paulsaxmd @NEJM https://t.co/KyJ8NX3CGk
-
-
Mashup Score: 1Covid-19 Vaccine Resource Center - 3 year(s) ago
The Covid-19 vaccine resource center includes a collection of articles, FAQs, and related content to help educate and empower clinicians and their practice.
Source: https://www.nejm.orgCategories: Cardiologists, Latest HeadlinesTweet-
NEJM —#Covid19 #Vaccine Resources https://t.co/nf6lwcoRJc
-
-
Mashup Score: 1Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
20. @PaulSaxMD https://t.co/1xMxo2bbBj
-
-
Mashup Score: 1Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: General Medicine News, Latest HeadlinesTweet-
The #COVID19vaccine FAQs from ID specialist @PaulSaxMD now include helpful answers on the J&J vaccine. Have a look: https://t.co/JjG2ogIrTh #covid19
-
-
Mashup Score: 1Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: Healthcare Professionals, Latest HeadlinesTweet-
Hey @NEJM, let's remember to add this to the FAQs https://t.co/Rz3FKYXmlQ https://t.co/2F0rcACgEu
-
-
Mashup Score: 8Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In our latest video, @PaulSaxMD shares his guidance on what to say to patients who are waiting for herd immunity instead of getting the #Covid19vaccine. Read all of our vaccine FAQs at https://t.co/ZcKRHEe3lz #IDTwitter https://t.co/5oLEvT2Fbt
-
-
Mashup Score: 6Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
ID specialist @PaulSaxMD provides guidance on how to approach concerns about the #Covid19vaccines from patients who are pregnant or breastfeeding. Read all of our vaccine FAQs at https://t.co/ZcKRHEvEd7 #IDTwitter https://t.co/3pJdtGzCWo
-
-
Mashup Score: 1Covid-19 Vaccine Frequently Asked Questions - 3 year(s) ago
Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination. Take a look below for his answers…
Source: https://www.nejm.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In a new video, @PaulSaxMD answers a question about patients with a history of allergic reactions and the #Covid19vaccines. Read all of our vaccine FAQs at https://t.co/ZcKRHEvEd7 #IDTwitter https://t.co/ZXl2pkkCjx
-
Right in the middle of ICML, we found out that CD20xCD3 bispecific antibody glofitamab had received FDA accelerated approval for relapsed or refractory diffuse large B-cell lymphoma, not otherwise specified or large B-cell lymphoma arising from follicular lymphoma, after two or more lines of systemic therapy. Very encouraging efficacy with seemingly lower rates of CRS and ICANS than CD19-directed CAR-T (though of course they have yet to be tested head-to-head). Check out the pivotal data in the New England Journal of Medicine.